NJ State Employees Deferred Compensation Plan’s Verve Therapeutics VERV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$157K Hold
2025
Q1
$64K Hold
2024
Q4
$79K Hold
2024
Q3
$67.8K Hold
2024
Q2
$68.3K Hold
2024
Q1
$186K Hold
2023
Q4
$195K Hold
2023
Q3
$186K Hold
2023
Q2
$263K Hold
2023
Q1
$202K Hold
2022
Q4
$271K Hold
2022
Q3
$481K Buy